glp 1 drugs and crohn's disease Primer: The Skinny on GLP-1s GLP-1 RAs and Crohn's Disease

This article examines current evidence on gastroparesis incidence, risk factors, diagnostic approaches, and management strategies for patients using GLP-1 medications

What Your Eye Doctor May Check During an eye exam, your optometrist may evaluate the optic nerve and retina carefully

A different take on obesity treatment GLP-1 drugs like semaglutide (the active ingredient of Ozempic and Wegovy) and tirzepatide (Zepbound and Mounjaro) have revolutionized obesity treatment in recent years

Common causes include infectious diseases (e.g., bacterial or viral infections), metabolic disorders (e.g., diabetic cardiomyopathy [DC], and amyloid-related myocardial changes), endocrine disorders (e.g., hyperthyroidism or hypothyroidism), connective tissue diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus), ischemic heart diseases (e.g., coronary atherosclerosis, coronary vasospasm), hypersensitivity reactions (e.g., allergic responses to penicillin or sulfonamide drugs), and toxic injuries (e.g., myocardial damage caused by bacterial toxins in typhoid fever)